Clinical and genomic factors associated with elacestrant outcomes in ESR1-mutant metastatic breast cancer. Lloyd MR, Weipert CM, Ali A, Solomon SR, et al. Clin Cancer Res 2025 Nov 7. doi: 10.1158/1078-0432.CCR-25-3033.

Read + Share

Amedeo Smart

Independent Medical Education

Lloyd MR, Weipert CM, Ali A, Solomon SR, et al. Clinical and genomic factors associated with elacestrant outcomes in ESR1-mutant metastatic breast cancer. Clin Cancer Res 2025 Nov 7. doi: 10.1158/1078-0432.CCR-25-3033.
PMID: 41201834